Full-Time

Regional Compliance Manager

Brenntag

Brenntag

10,001+ employees

Global distributor of chemicals and logistics

No salary listed

Neukirchen-Vluyn, Germany

Hybrid

Hybrid arrangement; some on-site days in Essen, Germany.

Master's

Category
Legal & Compliance (1)
Required Skills
Risk Management

Get referred to Brenntag

See people who can refer or advise you

Requirements
  • Minimum 5 years of relevant work experience in Compliance, legal, audit, or risk management
  • Master of Law / Business degree preferred, unless equivalent experience is demonstrated
  • Relevant Compliance certifications are an advantage
  • Deep understanding of how to analyze regulations and further develop and implement processes, policies, and trainings
  • High-motivation and ability to further develop, manage, and successfully lead project within a complex stakeholder environment
  • Ability to handle multiple, competing tasks and deadlines as part of an international team
  • High service-orientation, reliability, and with excellent interpersonal and intercultural communication skills
  • Entrepreneurial mindset and a willingness to innovate
  • Strong communication skills in English with the ability to effectively convey the company's core ethical values at all levels of the company
  • Knowledge of German or additional languages are an advantage
Responsibilities
  • Partner with business functions across the EMEA region to integrate Compliance requirements into day-to-day business processes and operations
  • Provide practical, business-oriented advice on Compliance matters and support stakeholders in identifying appropriate solutions
  • Support the ongoing development and maintenance of the Compliance Management System (CMS) to ensure its effectiveness and continuous improvement
  • Drive and support initiatives that promote a strong culture of ethics, integrity, and Compliance throughout the region
  • Develop, implement, and maintain Compliance processes and controls to identify, assess, and mitigate Compliance risks
  • Coordinate the regional whistleblowing process, including case intake, tracking, and collaboration with relevant stakeholders to ensure timely resolution
  • Prepare regular Compliance reports, metrics, and updates for the Regional Leadership Team and Group Compliance at the German headquarter
  • Increase Compliance awareness by developing communication initiatives and promoting understanding of Company policies and regulatory requirements
  • Monitor relevant legal and regulatory developments across the EMEA region and support the implementation of required policy and process updates
  • Plan, coordinate, and deliver Compliance training and awareness sessions for employees across the region

Brenntag is a global chemical distributor that connects manufacturers with users. It offers distribution, logistics, and value-added services to move chemicals efficiently across a broad network. The company differentiates itself with a large global reach and a wide range of supply-chain services that emphasize efficiency, sustainability, and transparency. Its goal is to help manufacturers reach target markets and ensure customers receive chemicals reliably while maintaining responsible and accountable operations.

Company Size

10,001+

Company Stage

IPO

Headquarters

Mülheim an der Ruhr, Germany

Founded

1874

Get referred to Brenntag

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 cost-out savings hit EUR 27 million, supporting full-year EBITDA guidance of EUR 1.15-1.35 billion.
  • Airedale closed in Q1 2026, strengthening Brenntag Essentials’ UK footprint and EMEA scale.
  • Brenntag’s biopharma push targets faster-growing regulated markets, from cell therapy ingredients to diagnostics.

What critics are saying

  • North Carolina sued Brenntag on June 9, 2026 over Durham creek contamination and cleanup orders.
  • Brenntag’s 2026 restructuring includes workforce reductions, site closures, and market exits through 2026.
  • Durham penalties reached $157,000 by 2026; unresolved pollution risks escalating injunctions and shutdowns.

What makes Brenntag unique

  • Brenntag’s 600-site network in 70 countries gives manufacturers immediate regulatory and logistics reach.
  • BYPHAR, launched April 23, 2026, packages biopharma raw materials into risk-tiered GMP offerings.
  • The July 1, 2026 Evonik REXIM deal makes Brenntag Europe’s exclusive GMP amino-acid distributor.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid parental leave

Education assistance program

Employee assistance program

Health Insurance

Dental Insurance

401(k) Company Match

401(k) Retirement Plan

Flexible Work Hours

Gym/Wellness subsidy

Tuition Reimbursement

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

8%

2 year growth

8%
Shalimar Infotech Pvt Ltd
Jul 24th, 2026
Brenntag: Availability of new BYPHAR Biopharma product range.

Brenntag: Availability of new BYPHAR Biopharma product range. 24 Jul 2026 Brenntag announces availability of new BYPHAR Biopharma product range - BYPHAR is Brenntag's Biopharma portfolio to simplify raw material selection and regulatory readiness - BYPHAR GMP samples for all products are available and will be released from Brenntag's Pharma GMP Hub Brenntag, the global market leader in chemicals and ingredients distribution, announced the commercial availability of the new Biopharma range BYPHAR. Brenntag announced the three-tier product portfolio supporting biopharmaceutical manufacturers from early R&D through commercial production with a global brand reveal in April. BYPHAR is Brenntag's Biopharma raw material portfolio designed to simplify raw material selection while helping manufacturers meet increasingly stringent regulatory and quality requirements across every stage of biopharmaceutical development and production. Developed specifically for the biopharmaceutical sector, BYPHAR brings together Brenntag's global distribution capabilities, regulatory expertise and technical services into a single, structured offering that enables customers to select raw materials based on application criticality and manufacturing phase. The portfolio supports manufacturers across monoclonal antibodies (mAbs), recombinant proteins, cell and gene therapies, vaccines, nucleic acid production, antibody-drug conjugates (ADCs), biosimilars and diagnostic manufacturing. As the biopharmaceutical industry continues to face increasing regulatory scrutiny, more complex supply chains and growing pressure to accelerate time-to-market, manufacturers require greater confidence in the quality, traceability and compliance of critical raw materials. BYPHAR has been developed to address these challenges through a regulatory-ready portfolio backed by comprehensive documentation, global supply reliability and technical support. "BYPHAR represents a major step forward in how we support our biopharma customers," said Gearoid O'Rourke, Senior Director Biopharma, Brenntag Pharma. "By combining high-quality raw materials and flexibility with global supply reliability and deep regulatory expertise, we are helping customers accelerate development and ensure the highest standards of all manufacturing stages." The BYPHAR portfolio is organized into three product categories aligned with manufacturing risk, allowing manufacturers to select material grades appropriate to their process, risk profile and stage of development: BYPHAR Explore supports research, process development and early-stage manufacturing with non-GMP materials intended for non-critical applications. Products are monograph compliant where applicable and supplied with essential regulatory documentation. BYPHAR Enhance provides GMP-compliant raw materials suitable throughout biopharmaceutical manufacturing. Produced in accordance with IPEC and EXCiPACT guidelines, the portfolio includes comprehensive regulatory-ready documentation to facilitate qualification and validation activities. BYPHAR Excel is designed for critical manufacturing applications, offering LBLE raw materials produced under GMP conditions. Products are multi-compendial where applicable and supported by extensive regulatory documentation to meet the highest standards for quality, compliance and supply assurance. For an intuitive customer journey and for customers to access product specifications, fact sheets and regulatory documentation packages, Brenntag will have a dedicated customer portal available in August. Alongside Brenntag's own-label products, BYPHAR also has co-branded materials from established manufacturing partners including Budenheim, Citribel, K+S and Kerry. The combined portfolio provides access to high-purity phosphates, citric acid and citrates, pharmaceutical-grade salts and acetates, supported by established manufacturing expertise and global supply capabilities. By combining global sourcing, quality systems, technical expertise and regulatory support under a single brand, BYPHAR is intended to help biopharma companies move from transactional procurement towards a more strategic supply partnership. About Brenntag Pharma: Brenntag Pharma is part of Brenntag, the global market leader in chemicals and ingredients distribution. Through its specialist pharma business, the company supplies pharmaceutical and biopharmaceutical manufacturers with high-quality ingredients, regulatory support, technical expertise and value-added services across Europe and international markets. Note: This story has not been edited by The Polymerupdate Editorial team and is auto-generated from a syndicated feed.

Evonik
Jul 15th, 2026
Evonik appoints Brenntag as the exclusive European distributor for REXIM(R) GMP-grade amino acids.

Evonik appoints Brenntag as the exclusive European distributor for REXIM(R) GMP-grade amino acids. * Brenntag to lead market development and distribution of REXIM(R) GMP-grade amino acids across most of Europe * Agreement strengthens customer access to high-quality amino acids for pharmaceutical and biopharmaceutical applications * Distributorship expands reach for GMP-grade amino acids in growing markets Evonik REXIM has entered into an agreement with Brenntag Specialties Pharma for the exclusive distribution of its REXIM(R) GMP-grade amino acids across most of Europe. Under the agreement, Brenntag will assume responsibility for market development and distribution in key regions including the DACH region, the UK, France, Benelux, Scandinavia, Central and Eastern Europe, Israel and Turkey. Italy, Ukraine, the Middle East and Africa are excluded from the agreement. "Our agreement with Brenntag significantly strengthens the market reach for our REXIM(R) amino acids," said Thomas Hermann, head of the REXIM product line at Evonik Health Care. "Brenntag's strong regional footprint, deep customer relationships, and extensive experience in the life-science sector make them an ideal partner. Together, we can provide customers with reliable access to high-quality GMP-grade amino acids and support the fast-growing pharmaceutical and biopharmaceutical markets." Evonik REXIM is a leading supplier of high-quality amino acids, with key production capabilities and supply sources located in Europe. The company combines market leadership in fermentation, bioconversion and synthetic-based manufacturing. Its collaboration with Brenntag supports Evonik's ambition for the REXIM(R) portfolio, expanding its presence in key global markets and providing customers with enhanced local service, technical support, and long-term supply security. "Our collaboration with Evonik reflects Brenntag's commitment to bringing high-value pharmaceutical ingredients and solutions closer to our customers," said Joakim Rehné, President Brenntag Pharma EMEA. "By combining Evonik's world-class expertise in GMP-grade amino acids with Brenntag's extensive market presence, technical capabilities, and regulatory know-how, we are uniquely positioned to support the evolving needs of pharmaceutical and biopharmaceutical manufacturers across the region. Together, we are creating a stronger, more reliable supply network that helps accelerate innovation and ensure patient access to critical therapies." Amino acids are fundamental building blocks of life and essential components of proteins, driving key biochemical and metabolic processes. REXIM(R) provides highly purified natural and non-natural amino acids. Their high quality and reliability make them suitable for a wide range of regulated applications, including medical nutrition, active pharmaceutical ingredients (APIs) and excipients, as well as nutrient components for cell culture media used in biopharmaceutical production. As a partner to the pharmaceutical industry, Evonik offers a broad, versatile portfolio of functional excipients, technologies, and contract manufacturing (CDMO) services for oral and parenteral dosage forms. End-to-end CDMO capabilities for small molecule APIs, highly potent APIs and intermediates, as well as high-quality innovative cell culture solutions (e.g., dipeptides, lipids, carbohydrates, surfactants) are also a cornerstone in Evonik's Health Care portfolio. Further information: Evonik: leading beyond chemistry. About custom solutions.

AD HOC NEWS
Jun 26th, 2026
Brenntag updates sustainability-linked financing, shares in focus after EUR 1.5 billion revolving cr

Brenntag SE has refinanced and expanded its core sustainability-linked syndicated revolving credit f

Haw River
Jun 12th, 2026
NC sues Brenntag - june 9, 2026.

NC sues Brenntag - june 9, 2026. FOR IMMEDIATE RELEASE june 10, 2026. Haw River Assembly Celebrates as NC Takes Legal Action Against Brenntag for Contaminating Waters in Durham Flowing to Jordan Lake North Carolina Attorney General and DEQ sue Durham chemical distributor over illegal discharge into Third Fork Creek BYNUM, N.C. - Haw River Assembly is celebrating with communities across Durham in regards to news that the North Carolina

Inside Climate News
Jun 10th, 2026
North Carolina sues chemical company for polluting a nearby creek.

North Carolina sues chemical company for polluting a nearby creek. Since 2023, the city of Durham has fined Brenntag $157,000 for violations related to water contamination. June 10, 2026 DURHAM, N.C. - Acetone and ethanol, 1,4-dioxane and "mucilaginous goo." For decades, state regulatory documents show, a chemical repackaging and distribution company in Durham has discharged high levels of toxic chemicals, as well as other unknown substances, into a neighborhood creek that flows behind an elementary school, through a public park in a predominantly Black neighborhood, and into a major drinking water supply. Now, the North Carolina attorney general is suing Brenntag Mid-South on behalf of state regulators over the alleged illegal releases, according to a complaint filed Monday in Durham Superior Court. The complaint alleges that Brenntag is violating North Carolina's water quality laws. The state is asking the court to require the company to submit a plan to eliminate the discharge and clean up previous contamination within 30 days. "I'm thrilled that the attorney general is intervening in this longstanding environmental injustice in Durham," said City Councilman Nate Baker. "The residents living around Burton Park and further downstream have suffered too long from the negligence of a large corporate neighbor, and it is time the harms rendered be repaired." Insideclimatenews deliver climate news to your inbox like nobody else. Every day or once a week, its original stories and digest of the web's top headlines deliver the full story, for free. A company spokesperson told Inside Climate News that Brenntag does not generally comment on ongoing litigation. Earlier this year the spokesperson provided a statement: "Brenntag Mid-South is committed to collaboration in this investigative process and continues to expend internal and external resources and expertise in coordination with local authorities." Brenntag Mid-South is a subsidiary of a global chemical company based in Germany. That company, Brenntag, reported $1 billion in gross profits in the first quarter of the year, according to public financial documents. Brenntag purchased the Durham property and its corporate owner, Southchem, in 2001. Over the last year the state Department of Environmental Quality, or DEQ, has repeatedly cited Brenntag for multiple violations related to water quality and reporting. Yet the company has failed to improve on both counts, according to the complaint. It has yet to file several required documents, including a plan to eliminate the discharge, the state said. Instead, the company has asked for extensions and then blown those deadlines, the complaint said. "Residents of Durham, and across this state, deserve clean water," DEQ Secretary Reid Wilson said in a prepared statement. "It's our job as the state environmental agency to ensure that companies are following the law, and today we take another step toward ensuring that for those living downstream of this facility." Based on testing data, state and city officials believe the groundwater is the source of the contamination, which then discharges into the creek through a pipe at the property line. Groundwater monitoring conducted in March by a Brenntag contractor showed that levels of more than a half-dozen chemicals exceeded state standards, including known carcinogens benzene and trichloroethene, also called TCE. Brenntag has long known about groundwater contamination at the site. The property at 2000 E. Pettigrew St. is a former cotton mill, which operated from the late 1800s through the 1930s and had its own lagoon. A Brenntag spokesperson told Inside Climate News last year that the issues affecting the creek "are complex and may be the result of multiple sources that are not yet known with certainty. Brenntag has taken numerous steps in close coordination with the City of Durham to help address these issues." Some of the polluting groundwater leaving the Brenntag site could originate from previous industrial processes. However, the plant has a long history of poor housekeeping: State records show inspectors have repeatedly found leaking and rusted barrels of chemicals, including as recently as November. This story is funded by readers like you. Its nonprofit newsroom provides award-winning climate coverage free of charge and advertising. Insideclimatenews rely on donations from readers like you to keep going. Please donate now to support its work. Regardless of the source, the company is still responsible for keeping contaminants from leaving the property. Since the city issued a no-discharge order in 2023, Brenntag has collected and shipped its water off-site and installed a remediation system to treat the groundwater. However, the company shut off the system two years ago without explanation, state records show. "There is stuff buried under there," Durham stormwater quality manager Michelle Woolfolk told the City Council last month. She said city officials had required Brenntag to test and identify a black material found in the creek, which the company had yet to do. Since 2023, the city of Durham has fined Brenntag $157,000 for various violations but has yet to collect the penalties in hopes the company would fix the problem. But Brenntag hasn't done so, according to Woolfolk's presentation to the City Council last month. "The contamination is getting worse," Haw Riverkeeper Emily Sutton, who routinely samples the creek, told the City Council. "It's an ongoing public health and environmental crisis. It's time to collect the penalties and accrue new ones until the discharge stops." Testing conducted by Brenntag contractors in April showed levels of acetone at 19,400 parts per billion, nearly 10 times the state surface water standard. Concentrations of ethanol have ranged from 25,000 to 144,000 parts per billion - five to almost 30 times the maximum allowed in surface water. The chemical 1,4-dioxane, which the Environmental Protection Agency concluded has the potential to cause cancer, consistently exceeded the agency's health advisory goals. "These are not historical readings," Sutton said. "It's what's in the water right now." In August 2023, the city fenced off the creek after Brenntag contractors detected high levels of acetone, toluene and ethanol in water at its property edge a half-mile upstream. City officials also collected what Woolfolk described as a ropy, brown "mucilaginous goo" from the creek. Since then, the creek, which runs through Durham's oldest and largest public housing community, has been off-limits. However, there are gaps in the plastic fencing, and it is easy to get into the creek. "I played in creeks all the time growing up," said City Councilwoman Javiera Caballero. "What are the kids in the neighborhood doing? It's hot. People will play in the creek." The contamination problem has persisted since at least the mid-1990s, state records show, when high levels of at least a dozen chemicals were detected in the groundwater and in stormwater runoff at the property. At times the creek has reeked so badly, a state environmental specialist wrote in 2004, that "Durham police have been called in to look for dead bodies." Brenntag owns two other facilities in North Carolina, in Greensboro and Charlotte. The Greensboro plant has a groundwater remediation system, installed by a previous owner, to treat contamination caused by spills and leaks that occurred before Brenntag purchased the property as part of a merger in 2000. DEQ has fined the Charlotte plant $83,000 since 2022 for improperly storing hazardous waste, failing to have an adequate evacuation plan and incomplete recordkeeping. About this story. Perhaps you noticed: This story, like all the news Insideclimatenews publish, is free to read. That's because Inside Climate News is a 501c3 nonprofit organization. Insideclimatenews do not charge a subscription fee, lock its news behind a paywall, or clutter its website with ads. Insideclimatenews make its news on climate and the environment freely available to you and anyone who wants it. That's not all. Insideclimatenews also share its news for free with scores of other media organizations around the country. Many of them can't afford to do environmental journalism of their own. Insideclimatenews has built bureaus from coast to coast to report local stories, collaborate with local newsrooms and co-publish articles so that this vital work is shared as widely as possible. Two of Insideclimatenews launched ICN in 2007. Six years later Insideclimatenews earned a Pulitzer Prize for National Reporting, and now Insideclimatenews run the oldest and largest dedicated climate newsroom in the nation. Insideclimatenews tell the story in all its complexity. Insideclimatenews hold polluters accountable. Insideclimatenews expose environmental injustice. Insideclimatenews debunk misinformation. Insideclimatenews scrutinize solutions and inspire action. Donations from readers like you fund every aspect of what Insideclimatenews do. If you don't already, will you support its ongoing work, its reporting on the biggest crisis facing its planet, and help Insideclimatenews reach even more readers in more places? Please take a moment to make a tax-deductible donation. Every one of them makes a difference. David Sassoon Founder and Publisher Vernon Loeb Executive Editor Reporter, North Carolina. Lisa Sorg is the North Carolina reporter for Inside Climate News. A journalist for 30 years, Sorg covers energy, climate environment and agriculture, as well as the social justice impacts of pollution and corporate malfeasance. She has won dozens of awards for her news, public service and investigative reporting. In 2022, she received the Stokes Award from the National Press Foundation for her two-part story about the environmental damage from a former missile plant on a Black and Latinx neighborhood in Burlington. Sorg was previously an environmental investigative reporter at NC Newsline, a nonprofit media outlet based in Raleigh. She has also worked at alt-weeklies, dailies and magazines. Originally from rural Indiana, she lives in Durham, N.C.